Organovo (ONVO) News Today $0.36 -0.01 (-3.28%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period The Tesla Model Y Is King. China's $21,000 Answer To It May Be BetterDecember 14, 2024 | msn.comOrganovo Holdings IncNovember 26, 2024 | money.usnews.comOrganovo Holdings Gains Approval for Key Strategic MovesNovember 23, 2024 | markets.businessinsider.comOrganovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver MeetingNovember 20, 2024 | globenewswire.comOrganovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver DiseasesNovember 13, 2024 | globenewswire.comONVO Releases Encouraging Quarterly ResultsNovember 12, 2024 | msn.comOrganovo files to sell common stock, warrants, no amount givenOctober 26, 2024 | markets.businessinsider.comOrganovo Holdings (NASDAQ:ONVO) Stock Quotes, Forecast and News SummaryOctober 13, 2024 | benzinga.comNio stock poised for 42% gain on ONVO sales momentumSeptember 28, 2024 | msn.comTesla Faces New Competition in China as Nio Launches Low-Cost SUVSeptember 21, 2024 | msn.comNio Drops Onvo L60 Price To Obliterate Tesla’s Model Y, Starts At $21KSeptember 21, 2024 | msn.comONVO Aug 2024 2.500 call (ONVO240816C00002500)August 13, 2024 | finance.yahoo.comOrganovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative ColitisJuly 16, 2024 | globenewswire.comOrganovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel DiseaseMay 21, 2024 | globenewswire.comOrganovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)May 14, 2024 | globenewswire.comOrganovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingMay 8, 2024 | globenewswire.comONVO Announces Very Positive Phase 2 ResultsMay 1, 2024 | finance.yahoo.comWhy Organovo Stock Is Up TodayApril 15, 2024 | msn.comOrganovo's fatty liver disease drug meets main goal in mid-stage studyApril 15, 2024 | reuters.comOrganovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboApril 15, 2024 | globenewswire.comOrganovo Holdings Stock (NASDAQ:ONVO) Earnings Dates and Earning CallsFebruary 24, 2024 | benzinga.comOrganovo Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 10, 2024 | finance.yahoo.comOrganovo Holdings Inc ONVOFebruary 9, 2024 | morningstar.comONVO Continues ProgressFebruary 9, 2024 | finance.yahoo.comOrganovo: Fiscal Q3 Earnings SnapshotFebruary 8, 2024 | sfgate.comOrganovo Holdings Unveils Corporate Presentation OnlineFebruary 8, 2024 | msn.comOrganovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressJanuary 25, 2024 | finance.yahoo.comOrganovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressJanuary 9, 2024 | finance.yahoo.comOrganovo, Inc.: Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsDecember 7, 2023 | finanznachrichten.deOrganovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsDecember 6, 2023 | finance.yahoo.comOVNO Continues Developing Breakthrough TreatmentsNovember 13, 2023 | msn.comCORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNovember 13, 2023 | finance.yahoo.comOrganovo Holdings Second Quarter 2024 Earnings: US$0.46 loss per share (vs US$0.38 loss in 2Q 2023)November 11, 2023 | finance.yahoo.comOrganovo Highlights FXR314 Combination Therapy Potential and PlanNovember 8, 2023 | finance.yahoo.comONVO, FATH and BYU among mid-day moversNovember 7, 2023 | msn.comONVO: A Company With Great Technology to Impact Health CareOctober 10, 2023 | finance.yahoo.comOrganovo to Participate in the H.C. Wainwright Global Investment ConferenceSeptember 8, 2023 | finance.yahoo.comIs Organovo Holdings (ONVO) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapAugust 25, 2023 | finance.yahoo.comOrganovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 DataAugust 23, 2023 | finance.yahoo.comOnvo receives $3 million grant from PennDOT to enhance electric vehicle charging infrastructureAugust 16, 2023 | msn.comONVO Organovo Holdings, Inc.July 29, 2023 | seekingalpha.comOnvo introduces first public fast electric vehicle chargers on I-81 stretchJuly 20, 2023 | msn.comOrganovo (NASDAQ: ONVO)June 7, 2023 | fool.comOrganovo Announces FXR ProgramMarch 21, 2023 | finance.yahoo.comWill Organovo Holdings (NASDAQ:ONVO) Spend Its Cash Wisely?February 10, 2023 | finance.yahoo.comOrganovo Holdings, Inc. (ONVO)October 25, 2022 | finance.yahoo.comTrends in 3D-Printing Materials Technology and the Global Market for the Most Promising New 3D-Printing Materials Applications - Yahoo FinanceOctober 17, 2022 | finance.yahoo.comHuman Liver Models Market Size Share Trends Growth Demand and Competitive Analysis Insights 2022-2029 | D - BenzingaOctober 12, 2022 | benzinga.com3D Bioprinting Market Size to Touch Valuation of $1.5 Billion by 2028 | Inkjet Technology Generates More than 38% Revenue of Bioprinting Market - GlobeNewswireOctober 9, 2022 | globenewswire.comARKG: Too Hard To Pin Down, Too Volatile For Comfort (BATS:ARKG) - Seeking AlphaOctober 3, 2022 | seekingalpha.com Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address This Crypto Is Set to Explode in December (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW ONVO Media Mentions By Week ONVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONVO News Sentiment▼0.000.60▲Average Medical News Sentiment ONVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONVO Articles This Week▼10▲ONVO Articles Average Week Get Organovo News Delivered to You Automatically Sign up to receive the latest news and ratings for ONVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MiNK Therapeutics News Today Chemomab Therapeutics News Today Equillium News Today Calidi Biotherapeutics News Today Athira Pharma News Today Lisata Therapeutics News Today Pulmatrix News Today IN8bio News Today GeoVax Labs News Today iBio News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONVO) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organovo Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organovo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
